Company intelligence / Profile preview

Physician's Choice

Ownership: Private
Development stage: Other

Overview

Physician’s Choice markets science-backed probiotic and prebiotic supplements developed with input from doctors and researchers. Their flagship 60 Billion Probiotic contains 10 diverse strains to support gut health. The company claims over 10 million bottles sold and more than 70k verified five-star reviews on Amazon. Clinical results are based on published research about the included strains rather than proprietary clinical trials.

Therapeutic areas: GastroenterologyImmunologyEndocrinology
Modalities: Live biotherapeutic product therapy (probiotics)Prebiotic supplement
Industry: Food & Nutrition

Beyond the preview

Go deeper on Physician's Choice.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physician's Choice.

Explore the full profile